A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

Sarcomatoid features can arise in renal cell carcinoma of any subtype and are associated with a poor prognosis. Doxorubicin and gemcitabine in a limited series showed activity in aggressive renal tumors and we wished to formally assess the combination in patients with renal cell carcinoma specifical...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Haas, Naomi B., Lin, Xinyi, Manola, Judith, Pins, Michael, Liu, Glenn, McDermott, David, Nanus, David, Heath, Elisabeth, Wilding, George, Dutcher, Janice
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566570/
https://ncbi.nlm.nih.gov/pubmed/21298497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-011-9829-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky